Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system

American Journal of Obstetrics and Gynecology

Volumn 216, Issue 2, 2017, Pages 151.e1-151.e9

  Chao, Chun ^a   Silverberg, Michael J ^b   Becerra, Tracy A ^a   Corley, Douglas A ^b   Jensen, Christopher D ^b   Chen, Qiaoling ^a   Quinn, Virginia P ^a  

^a KAISER PERMANENTE   (United States)

^b DIVISION OF RESEARCH   (United States)

Author keywords

cervical cancer; human Papillomavirus vaccine; Papanicolaou test; screening behavior

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; CANCER SCREENING; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH CARE UTILIZATION; HUMAN; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UTERINE CERVIX CANCER; VACCINATION; WART VIRUS; CALIFORNIA; EARLY CANCER DIAGNOSIS; ODDS RATIO; PAPILLOMAVIRUS INFECTIONS; PROPORTIONAL HAZARDS MODEL; PROTOCOL COMPLIANCE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UTERINE CERVICAL NEOPLASMS; UTILIZATION; VAGINA SMEAR; YOUNG ADULT;

ADULT; CALIFORNIA; EARLY DETECTION OF CANCER; FEMALE; GUIDELINE ADHERENCE; HUMANS; LOGISTIC MODELS; ODDS RATIO; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 85010916135     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2016.10.006     Document Type: Article

References (22)

1. 1 Rahman, M., McGrath, C.J., Hirth, J.M., Berenson, A.B., Age at HPV vaccine initiation and completion among US adolescent girls: trend from 2008 to 2012. Vaccine 33 (2015), 585–587.
2. 2 Reagan-Steiner, S., Yankey, D., Jeyarajah, J., et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years: United States, 2014. MMWR Morb Mortal Wkly Rep 64 (2015), 784–792.
3. 3 Anhang Price, R., Koshiol, J., Kobrin, S., Tiro, J.A., Knowledge and intention to participate in cervical cancer screening after the human papillomavirus vaccine. Vaccine 29 (2011), 4238–4243.
4. 4 Mullins, T.L., Zimet, G.D., Rosenthal, S.L., et al. Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination. Arch Pediatr Adolesc Med 166 (2012), 82–88.
5. 5 Kulasingam, S.L., Pagliusi, S., Myers, E., Potential effects of decreased cervical cancer screening participation after HPV vaccination: an example from the U.S. Vaccine 25 (2007), 8110–8113.
6. 6 Paul-Ebhohimhen, V., Huc, S., Tissington, H., Oates, K., Stark, C., HPV vaccination: vaccine acceptance, side effects and screening intentions. Community Pract 83 (2010), 30–33.
7. 7 Mather, T., McCaffery, K., Juraskova, I., Does HPV vaccination affect women's attitudes to cervical cancer screening and safe sexual behaviour?. Vaccine 30 (2012), 3196–3201.
8. 8 Bowyer, H.L., Dodd, R.H., Marlow, L.A., Waller, J., Association between human papillomavirus vaccine status and other cervical cancer risk factors. Vaccine 32 (2014), 4310–4316.
9. 9 Hirth, J.M., Lin, Y.L., Kuo, Y.F., Berenson, A.B., Effect of number of human papillomavirus vaccine doses on guideline adherent cervical cytology screening among 19-26 year old females. Prev Med 88 (2016), 134–139.
10. 10 Paynter, C.A., Van Treeck, B.J., Verdenius, I., et al. Adherence to cervical cancer screening varies by human papillomavirus vaccination status in a high-risk population. Prev Med Rep 2 (2015), 711–716.
11. 11 Koebnick, C., Langer-Gould, A.M., Gould, M.K., et al. Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Perm J 16 (2012), 37–41.
12. 12 Von Elm, E., Altman, D.G., Egger, M., et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61 (2008), 344–349.
13. 13 Moyer, V.A., Force US Preventive Services Task Force. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 156 (2012), 880–891 W312. Erratum: Ann Intern Med 2013;158:852.
14. 14 Administration USFaD. Gardasil (human papillomavirus vaccine) Questions and Answers - Gardasil, June 8, 2006. Available at: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/ucm096052.htm. Accessed January 7, 2016.
15. 15 Saslow, D., Runowicz, C.D., Solomon, D., et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 52 (2002), 342–362.
16. 16 Vogt, T.M., Feldstein, A.C., Aickin, M., Hu, W.R., Uchida, A.R., Electronic medical records and prevention quality: the prevention index. Am J Prev Med 33 (2007), 291–296.
17. 17 Vogt, T.M., Aickin, M., Ahmed, F., Schmidt, M., The Prevention Index: using technology to improve quality assessment. Health Serv Res 39 (2004), 511–530.
18. 18 Kuitto, K., Pickel, S., Neumann, H., Jahn, D., Metelmann, H.-R., Attitudinal and socio-structural determinants of cervical cancer screening and HPV vaccination uptake: a quantitative multivariate analysis. J Public Health 18 (2010), 179–188.
19. 19 Beer, H., Hibbitts, S., Brophy, S., Rahman, M.A., Waller, J., Paranjothy, S., Does the HPV vaccination programme have implications for cervical screening programmes in the UK?. Vaccine 32 (2014), 1828–1833.
20. 20 Budd, A.C., Brotherton, J.M., Gertig, D.M., Chau, T., Drennan, K.T., Saville, M., Cervical screening rates for women vaccinated against human papillomavirus. Med J Aust 201 (2014), 279–282.
21. 21 Finer, L.B., Philbin, J.M., Sexual initiation, contraceptive use, and pregnancy among young adolescents. Pediatrics 131 (2013), 886–891.
22. 22 Bailey, H.H., Chuang, L.T., duPont, N.C., et al. American Society of Clinical Oncology Statement: human papillomavirus vaccination for cancer prevention. J Clin Oncol 34 (2016), 1803–1812.